Oak Harvest Investment Services’s Teva Pharmaceuticals TEVA Stock Holding History

Oak Harvest Investment Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.98M	Buy	146,945 +27,427	+23%	+$914K	0.46%	73
2026 Q1	$3.67M	Sell	119,518 -7,868	-6%	-$253K	0.38%	80
2025 Q4	$3.98M	Buy	127,386 +77,386	+155%	+$1.91M	0.43%	78
2025 Q3	$1.01M	Buy	+50,000	New	+$878K	0.12%	112

Other funds holding TEVA

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

UBP

Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

SCM

Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Oak Harvest Investment Services's TEVA Position: Q2 2026 in Review

Oak Harvest Investment Services increased its Teva Pharmaceuticals (TEVA) stake by 23% in Q2 2026, buying an estimated $914K and bringing the position to 146,945 shares worth $4.98M. The position accounts for 0.46% of the portfolio, ranked #73.

Oak Harvest Investment Services first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Oak Harvest Investment Services held 146,945 shares of Teva Pharmaceuticals worth $4.98M as of Q2 2026.
Oak Harvest Investment Services bought 27,427 Teva Pharmaceuticals shares in Q2 2026, an estimated $914K.
Teva Pharmaceuticals made up 0.46% of Oak Harvest Investment Services's portfolio in Q2 2026, its #73 holding.
Oak Harvest Investment Services first reported a position in Teva Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
183 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Oak Harvest Investment Services's 13F filing for Q2 2026, filed 27 Jul 2026.